Bone metastasis: mechanisms, therapies, and biomarkers
Skeletal metastases are frequent complications of many cancers, causing bone
complications (fractures, bone pain, disability) that negatively affect the patient's quality of …
complications (fractures, bone pain, disability) that negatively affect the patient's quality of …
CXCL13 and its receptor CXCR5 in cancer: inflammation, immune response, and beyond
MG Kazanietz, M Durando, M Cooke - Frontiers in endocrinology, 2019 - frontiersin.org
It is well-established that the chemokine CXC motif ligand 13 (CXCL13) and its receptor, the
G-protein coupled receptor (GPCR) CXCR5, play fundamental roles in inflammatory …
G-protein coupled receptor (GPCR) CXCR5, play fundamental roles in inflammatory …
[HTML][HTML] Intratumoral CXCL13+ CD8+ T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell …
S Dai, H Zeng, Z Liu, K Jin, W Jiang… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Chemokine (CXC motif) ligand 13 (CXCL13) was known as a selective
chemotaxis for B cells, a product of follicular helper CD4+ T cells (T FH) and a contributor to …
chemotaxis for B cells, a product of follicular helper CD4+ T cells (T FH) and a contributor to …
Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor
BH Li, MA Garstka, ZF Li - Molecular immunology, 2020 - Elsevier
Myeloid-derived suppressor cells (MDSCs) expand in tumor-bearing host. They suppress
anti-tumor immune response and promote tumor growth. Chemokines play a vital role in …
anti-tumor immune response and promote tumor growth. Chemokines play a vital role in …
B cell and B cell-related pathways for novel cancer treatments
R Tokunaga, M Naseem, JH Lo, F Battaglin… - Cancer treatment …, 2019 - Elsevier
B cells are recognized as the main effector cells of humoral immunity which suppress tumor
progression by secreting immunoglobulins, promoting T cell response, and killing cancer …
progression by secreting immunoglobulins, promoting T cell response, and killing cancer …
[HTML][HTML] CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer
B Wang, M Wang, D Ao, X Wei - … et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
Chemokine CXC motif ligand 13 (CXCL13), originally identified as a B-cell chemokine, plays
an important role in the immune system. The interaction between CXCL13 and its receptor …
an important role in the immune system. The interaction between CXCL13 and its receptor …
CXCL13/CXCR5 signaling axis in cancer
The tumor microenvironment comprises stromal and tumor cells which interact with each
other through complex cross-talks that are mediated by a variety of growth factors, cytokines …
other through complex cross-talks that are mediated by a variety of growth factors, cytokines …
The role of selected chemokines and their receptors in the development of gliomas
M Groblewska, A Litman-Zawadzka… - International journal of …, 2020 - mdpi.com
Among heterogeneous primary tumors of the central nervous system (CNS), gliomas are the
most frequent type, with glioblastoma multiforme (GBM) characterized with the worst …
most frequent type, with glioblastoma multiforme (GBM) characterized with the worst …
Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
M Ammirante, S Shalapour, Y Kang… - Proceedings of the …, 2014 - National Acad Sciences
Prostate cancer (PC) is a slowly progressing malignancy that often responds to androgen
ablation or chemotherapy by becoming more aggressive, acquiring a neuroendocrine …
ablation or chemotherapy by becoming more aggressive, acquiring a neuroendocrine …
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy
MP Chao, C Tang, RK Pachynski… - Blood, The Journal …, 2011 - ashpublications.org
Non-Hodgkin lymphoma (NHL) presents as both localized and disseminated disease with
spread to secondary sites carrying a worse prognosis. Although pathways driving NHL …
spread to secondary sites carrying a worse prognosis. Although pathways driving NHL …